secwatch.observer — SEC 8-K summary
======================================

Issuer:     ENANTA PHARMACEUTICALS INC (ENTA)
CIK:        0001177648
Form:       8-K
Filed at:   2025-10-01T23:59:59+00:00
Accession:  0001193125-25-226828
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Enanta Pharmaceuticals prices public offering of 6.5M shares at $10/share, expects ~$60.6M net proceeds
--------------------------------------------------------------------------------

- 6,500,000 shares offered at $10.00 per share; underwriters have 30-day option for 975,000 more shares.
- Expected net proceeds of approximately $60.6 million after underwriting discounts and offering expenses.
- Offering expected to close on October 2, 2025, subject to customary closing conditions.
- Underwriting agreement with J.P. Morgan, Jefferies, and Evercore dated September 30, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1177648/000119312525226828/0001193125-25-226828-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1177648/000119312525226828/d81869d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-226828

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer